jg 365 has been researched along with mvt 101 in 4 studies
| Studies (jg 365) | Trials (jg 365) | Recent Studies (post-2010) (jg 365) | Studies (mvt 101) | Trials (mvt 101) | Recent Studies (post-2010) (mvt 101) |
|---|---|---|---|---|---|
| 16 | 0 | 0 | 14 | 0 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gustchina, A; Swain, AL; Wlodawer, A | 1 |
| Appelt, K; Freer, ST; Verkhivker, G; Villafranca, JE | 1 |
| Hwang, MJ; Lee, CY; Tzou, WS; Yang, PK | 1 |
| Florián, J; Johnson, EC; Kent, SB; Malito, E; Pentelute, B; Rich, D; Shen, Y; Tang, WJ | 1 |
4 other study(ies) available for jg 365 and mvt 101
| Article | Year |
|---|---|
Comparison of three inhibitor complexes of human immunodeficiency virus protease.
Topics: Amino Acid Sequence; Binding Sites; HIV Protease; HIV Protease Inhibitors; Molecular Sequence Data; Molecular Structure; Oligopeptides; Protease Inhibitors; Protein Conformation | 1991 |
Empirical free energy calculations of ligand-protein crystallographic complexes. I. Knowledge-based ligand-protein interaction potentials applied to the prediction of human immunodeficiency virus 1 protease binding affinity.
Topics: Crystallization; HIV Protease; HIV Protease Inhibitors; Humans; Ligands; Models, Chemical; Oligopeptides; Protein Binding; Substrate Specificity; Thermodynamics; Water | 1995 |
Estimates of relative binding free energies for HIV protease inhibitors using different levels of approximations.
Topics: Chemical Phenomena; Chemistry, Physical; HIV Protease; HIV Protease Inhibitors; Methylurea Compounds; Oligopeptides; Pyridines; Sugar Alcohols; Thermodynamics; Valine | 1998 |
Insights from atomic-resolution X-ray structures of chemically synthesized HIV-1 protease in complex with inhibitors.
Topics: Binding Sites; Crystallography, X-Ray; Drug Design; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Models, Molecular; Molecular Sequence Data; Oligopeptides; Protein Conformation; X-Ray Diffraction | 2007 |